203 related articles for article (PubMed ID: 25254640)
21. Receptor binding mode and pharmacological characterization of a potent and selective dual CXCR1/CXCR2 non-competitive allosteric inhibitor.
Bertini R; Barcelos LS; Beccari AR; Cavalieri B; Moriconi A; Bizzarri C; Di Benedetto P; Di Giacinto C; Gloaguen I; Galliera E; Corsi MM; Russo RC; Andrade SP; Cesta MC; Nano G; Aramini A; Cutrin JC; Locati M; Allegretti M; Teixeira MM
Br J Pharmacol; 2012 Jan; 165(2):436-54. PubMed ID: 21718305
[TBL] [Abstract][Full Text] [Related]
22. Differential activation and regulation of CXCR1 and CXCR2 by CXCL8 monomer and dimer.
Nasser MW; Raghuwanshi SK; Grant DJ; Jala VR; Rajarathnam K; Richardson RM
J Immunol; 2009 Sep; 183(5):3425-32. PubMed ID: 19667085
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of potent and selective small-molecule antagonists for the CXCR2 chemokine receptor.
Widdowson KL; Elliott JD; Veber DF; Nie H; Rutledge MC; McCleland BW; Xiang JN; Jurewicz AJ; Hertzberg RP; Foley JJ; Griswold DE; Martin L; Lee JM; White JR; Sarau HM
J Med Chem; 2004 Mar; 47(6):1319-21. PubMed ID: 14998320
[TBL] [Abstract][Full Text] [Related]
24. Pharmacological characterization of AZD5069, a slowly reversible CXC chemokine receptor 2 antagonist.
Nicholls DJ; Wiley K; Dainty I; MacIntosh F; Phillips C; Gaw A; Mårdh CK
J Pharmacol Exp Ther; 2015 May; 353(2):340-50. PubMed ID: 25736418
[TBL] [Abstract][Full Text] [Related]
25. Probing the role of CXC motif in chemokine CXCL8 for high affinity binding and activation of CXCR1 and CXCR2 receptors.
Joseph PR; Sarmiento JM; Mishra AK; Das ST; Garofalo RP; Navarro J; Rajarathnam K
J Biol Chem; 2010 Sep; 285(38):29262-9. PubMed ID: 20630874
[TBL] [Abstract][Full Text] [Related]
26. CXCL8((3-73))K11R/G31P antagonizes ligand binding to the neutrophil CXCR1 and CXCR2 receptors and cellular responses to CXCL8/IL-8.
Li F; Zhang X; Gordon JR
Biochem Biophys Res Commun; 2002 May; 293(3):939-44. PubMed ID: 12051749
[TBL] [Abstract][Full Text] [Related]
27. Discrete steps in binding and signaling of interleukin-8 with its receptor.
Wu L; Ruffing N; Shi X; Newman W; Soler D; Mackay CR; Qin S
J Biol Chem; 1996 Dec; 271(49):31202-9. PubMed ID: 8940121
[TBL] [Abstract][Full Text] [Related]
28. Differential Effects of Posttranslational Modifications of CXCL8/Interleukin-8 on CXCR1 and CXCR2 Internalization and Signaling Properties.
Vacchini A; Mortier A; Proost P; Locati M; Metzemaekers M; Borroni EM
Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30486423
[TBL] [Abstract][Full Text] [Related]
29. Elucidation of Distinct Roles of Guinea Pig CXCR1 and CXCR2 in Neutrophil Migration toward IL-8 and GROα by Specific Antibodies.
Tanaka K; Yoshitomi T; Hirahara K
Biol Pharm Bull; 2017; 40(5):729-732. PubMed ID: 28458362
[TBL] [Abstract][Full Text] [Related]
30. Rabbit neutrophil chemotactic protein (NCP) activates both CXCR1 and CXCR2 and is the functional homologue for human CXCL6.
Catusse J; Struyf S; Wuyts A; Weyler M; Loos T; Gijsbers K; Gouwy M; Proost P; Van Damme J
Biochem Pharmacol; 2004 Nov; 68(10):1947-55. PubMed ID: 15476666
[TBL] [Abstract][Full Text] [Related]
31. Expression of CXCL8, CXCR1, and CXCR2 in neurons and glial cells of the human and rabbit retina.
Goczalik I; Ulbricht E; Hollborn M; Raap M; Uhlmann S; Weick M; Pannicke T; Wiedemann P; Bringmann A; Reichenbach A; Francke M
Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4578-89. PubMed ID: 18552386
[TBL] [Abstract][Full Text] [Related]
32. The antagonist of CXCR1 and CXCR2 protects
Cui S; Qiao L; Yu S; Men L; Li Y; Li F; Du J
Am J Physiol Endocrinol Metab; 2019 Dec; 317(6):E1205-E1217. PubMed ID: 31573846
[TBL] [Abstract][Full Text] [Related]
33. Granulocyte chemotactic protein 2 acts via both IL-8 receptors, CXCR1 and CXCR2.
Wolf M; Delgado MB; Jones SA; Dewald B; Clark-Lewis I; Baggiolini M
Eur J Immunol; 1998 Jan; 28(1):164-70. PubMed ID: 9485196
[TBL] [Abstract][Full Text] [Related]
34. The combined CXCR1/CXCR2 antagonist CXCL8(3-74)K11R/G31P blocks neutrophil infiltration, pyrexia, and pulmonary vascular pathology in endotoxemic animals.
Gordon JR; Li F; Zhang X; Wang W; Zhao X; Nayyar A
J Leukoc Biol; 2005 Dec; 78(6):1265-72. PubMed ID: 16204619
[TBL] [Abstract][Full Text] [Related]
35. Cross-desensitization among CXCR1, CXCR2, and CCR5: role of protein kinase C-epsilon.
Nasser MW; Marjoram RJ; Brown SL; Richardson RM
J Immunol; 2005 Jun; 174(11):6927-33. PubMed ID: 15905535
[TBL] [Abstract][Full Text] [Related]
36. ELR-CXC chemokine receptor antagonism targets inflammatory responses at multiple levels.
Zhao X; Town JR; Li F; Zhang X; Cockcroft DW; Gordon JR
J Immunol; 2009 Mar; 182(5):3213-22. PubMed ID: 19234219
[TBL] [Abstract][Full Text] [Related]
37. LPS challenge in healthy subjects: an investigation of neutrophil chemotaxis mechanisms involving CXCR1 and CXCR2.
Aul R; Patel S; Summerhill S; Kilty I; Plumb J; Singh D
Int Immunopharmacol; 2012 Jul; 13(3):225-31. PubMed ID: 22561413
[TBL] [Abstract][Full Text] [Related]
38. Differential cross-regulation of the human chemokine receptors CXCR1 and CXCR2. Evidence for time-dependent signal generation.
Richardson RM; Pridgen BC; Haribabu B; Ali H; Snyderman R
J Biol Chem; 1998 Sep; 273(37):23830-6. PubMed ID: 9726994
[TBL] [Abstract][Full Text] [Related]
39. Small molecule antagonists of the CXCR2 and CXCR1 chemokine receptors as therapeutic agents for the treatment of inflammatory diseases.
Busch-Petersen J
Curr Top Med Chem; 2006; 6(13):1345-52. PubMed ID: 16918453
[TBL] [Abstract][Full Text] [Related]
40. CXCR2 stimulation primes CXCR1 [Ca2+]i responses to IL-8 in human neutrophils.
Hauser CJ; Fekete Z; Goodman ER; Kleinstein E; Livingston DH; Deitch EA
Shock; 1999 Dec; 12(6):428-37. PubMed ID: 10588510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
